3.89 USD
↗ 0.01 (0.26%)AT CLOSE (11:59 AM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
3.89
↘ 0.00 (0.03%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
3.89
↘ 0.00 (0.03%)
Market: CLOSED
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $3.88. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 26, 2026.
Open?$3.87
High?$3.93
Low?$3.83
Prev. Close?$3.88
Volume?576.2K
Avg. Volume?1.2M
VWAP?$3.89
Rel. Volume?0.46x
Bid / Ask
Bid?$3.85 × 100
Ask?$3.93 × 100
Spread?$0.08
Midpoint?$3.89
Valuation & Ratios
Market Cap?368.3M
Shares Out?71.7M
Float?49.8M
Float %?69.5%
P/E Ratio?N/A
P/B Ratio?2.56
EPS?-$1.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
367.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?35
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.72Distress
Confidence?65%Moderate
Short InterestHigh
Short % of Float?11.98%High
Short Interest?6.0M
Days to Cover?5.3
Free Float49.8M
Avg Daily Volume1.1M
Settlement Date2026-08-14
Financial Health
Current Ratio?4.82Strong
Quick Ratio?4.82Strong
Cash Ratio?0.66Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.56CHEAP▾
Peers100
S&P63
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-97.2%WEAK▾
S&P3
ROA?-64.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-128129000
Enterprise Value?$343.5M
Fundamentals ratios updated end of day